Bicycle Therapeutics (BCYC) Change in Accured Expenses (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Change in Accured Expenses data on file, last reported at -$2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 71.33% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.9 million (up 44.13% YoY), and the FY2025 full-year result was $4.1 million, down 57.8% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$2.4 million, down from $2.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $11.5 million in Q2 2023 and bottomed at -$8.2 million in Q1 2025.
• The 5-year median for Change in Accured Expenses is $1.8 million (2024), against an average of $1.5 million.
• The widest annual swing landed in 2022, when Change in Accured Expenses soared 2687.8%; it then plunged 202.01% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at $6.9 million in 2022, then sank by 153.68% to -$3.7 million in 2023, then jumped by 201.63% to $3.7 million in 2024, then plunged by 46.61% to $2.0 million in 2025, then tumbled by 217.65% to -$2.4 million in 2026.
• The last three Change in Accured Expenses figures came in at -$2.4 million (Q1 2026), $2.0 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison